Adverse Reactions After Intradermal Vaccination With JYNNEOS for Mpox in Korea
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (8) , e100
Abstract
Lim SY, et al. J Korean Med Sci. 2024 Feb;39(8):e100. https://doi.org/10.3346/jkms.2024.39.e100Keywords
This publication has 6 references indexed in Scilit:
- JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional studyOsong Public Health and Research Perspectives, 2023
- Safety of Monkeypox Vaccine Using Active Surveillance, Two-Center Observational Study in ItalyVaccines, 2023
- Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for MpoxJAMA, 2023
- Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022MMWR. Morbidity and Mortality Weekly Report, 2022
- Monkeypox Vaccination in the Republic of Korea: Identifying the High-Risk Target GroupJournal of Korean Medical Science, 2022
- Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjectsVaccine, 2015